The European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for BAT2506 as a biosimilar to reference p ...

Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for ...

A large European study finds that TNF inhibitors work differently across joints in psoriatic arthritis, with the shoulder and ...

Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and ...

The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

Biologics License Applications for AVT05, their proposed biosimilar to the anti-inflammatory drugs Simponi and Simponi Aria. Review of the applications is expected to by completed in Q4 2025, ...

Psoriatic Arthritis vs. Gout: What Are the Differences? Psoriatic Arthritis vs. Ankylosing Spondylitis: What Are the Differences? Psoriatic Arthritis vs. Sacroiliitis: What Are the Differences?

Inflammatory arthritis like psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis are treated by a rheumatologist. Osteoarthritis treatment can be administered by multiple providers in ...

to treat patients who have active psoriatic arthritis, active nonradiographic axial spondyloarthritis and objective signs of inflammation, and active ankylosing spondylitis. 2 In the trials ...